Results 271 to 280 of about 23,559,862 (313)
Some of the next articles are maybe not open access.
Integrin expression in non-small cell carcinoma of the lung
Cancer and Metastasis Reviews, 1995Alteration of integrin expression in a number of different malignant diseases has been recognized, with a trend of downregulation of collagen-laminin binding integrin expression in epithelial tumor types noted. This study evaluated the expression of a panel of integrin subunits that included subunits that form receptors that bind to collagen and ...
W R, Smythe +4 more
openaire +2 more sources
Curative radiotherapy in non-small cell carcinoma of the lung
International Journal of Radiation Oncology*Biology*Physics, 1990Recent reports suggest radiotherapy administered to the 5000-6000 cGy level can result in significant long-term survival in non-small cell carcinoma of the lung. This is particularly true for many cases that are technically operable but for medical or other reasons thoracotomy cannot be performed.
B M, Talton, W C, Constable, C R, Kersh
openaire +2 more sources
Molecular Diagnostics in Non-Small Cell Lung Carcinoma
Seminars in Respiratory and Critical Care Medicine, 2020AbstractCurrent clinical practice guidelines recognize EGFR, BRAF, ALK, and ROS1 as essential molecular biomarkers, and a host of other genetic alterations as emerging biomarkers for non-small cell lung carcinoma patients. The available approaches to detecting relevant alterations in these genes are diverse and often complementary.
openaire +2 more sources
Elastase levels in small and non - small cell lung carcinoma
Biochemical Society Transactions, 1993Elastase (E.C.3.4.21.37) constitutes the most important component in the proteolytic enzyme spectrum of neutrophilic granulocytes [ I ] . Elastase is the only enzyme which can hydrolyze insoluble elastin 121. In addition, elastase can hydrolyze several other tissue components including connective tissue macromolecules, plasma proteinase inhibitors and ...
Güner, G +4 more
openaire +4 more sources
Expression of mage genes by non‐small‐cell lung carcinomas
International Journal of Cancer, 1994AbstractHuman gene MAGE‐1 codes for an antigen that is recognized on melanoma cells by autologous cytolytic T lymphocytes (CTL). This antigen is potentially useful as a target for cancer immunotherapy because gene MAGE‐1 is not expressed in any normal tissues except the testis.
Weynants, Patrick +4 more
openaire +3 more sources
Chromogranin A gene expression in non‐small cell lung carcinomas
The Journal of Pathology, 1998Evidence for the existence of neuroendocrine (NE) differentiation in non-small cell lung carcinomas (NSCLCs) is at present based on histochemical, ultrastructural, and immunohistochemical data. The aim of this study was to investigate the extent of NE differentiation in NSCLCs as revealed by mRNA analysis.
ABBONA G. +5 more
openaire +3 more sources
K-ras Mutations in Non-Small-Cell Lung Carcinoma: A Review
Clinical Lung Cancer, 2006The Ras proteins are pivotal regulators of cellular proliferation, differentiation, motility, and apoptosis. Mutations on the K-ras gene have been found in 20%-30% of non-small-cell lung cancers and are believed to play a key role in this malignancy. Herein, we review the complex biochemical mechanisms through which K-ras exerts its cellular effects ...
Aviel-Ronen, S +3 more
openaire +2 more sources

